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159 Ovine panel reactive antibody assay of HLA responsivity to allograft
bioengineered vascular scaffolds
Ara Ketchedjian, MD, Paula Kreuger, BS, Howard Lukoff, BS, Elliot Robinson, BS,
Alyce Linthurst-Jones, MS, Katrina Crouch, BS, Lloyd Wolfinbarger, PhD, and
Richard Hopkins, MD, Providence, RI, and Virginia Beach, Va
Bioengineered vascular constructs designed to eliminate the antigens that promote
allosensitization and increases in PRA might avoid immune inflammatory consequences that
limit longevity and tissue durability. We modified a human PRA detection method to work with




167 Conventional and sutureless techniques for management of the pulmonary
veins: Evolution of indications from postrepair pulmonary vein stenosis to
primary pulmonary vein anomalies
Tae-Jin Yun, MD, John G. Coles, MD, Igor E. Konstantinov, MD, PhD,
Osman O. Al-Radi, MD, Rachel M. Wald, MD, Vitor Guerra, MD, Nilto C. de Oliveira, MD,
Glen S. Van Arsdell, MD, William G. Williams, MD, Jeffrey Smallhorn, MD, and
Christopher A. Caldarone, MD, Toronto, Ontario, Canada
The sutureless technique for postrepair pulmonary vein stenosis is associated with encouraging
midterm results. Extension of the indications to other pulmonary vein anomalies without
previous cardiac operations appears safe with the development of simple intraoperative
maneuvers.
175 Preliminary results of fetal cardiac bypass in nonhuman primates
Akio Ikai, MD, R. Kirk Riemer, PhD, Chandra Ramamoorthy, MD, Sunil Malhatra, MD,
Lydia Cassorla, MD, Gabriel Amir, MD, Frank L. Hanley, MD, and V. Mohan Reddy, MD,
Stanford and San Francisco, Calif, and New York, NY
Fetal cardiac surgery has benefits for treatment of some congenital heart defects. The technical
feasibility of cardiac bypass in nonhuman primate fetuses weighing less than 1000 g was
confirmed and included no maternal mortality. Isoflurane anesthesia appears to be superior to
fentanyl and midazolam anesthesia because of adequate uterine relaxation.
182 Long-term outcome of surgically treated patients with corrected
transposition of the great arteries
Viktor Hraska, MD, Brian W. Duncan, MD, John E. Mayer, Jr, MD, Michael Freed, MD,
Pedro J. del Nido, MD, and Richard A. Jonas, MD, Hamburg–Eppendorf, Germany; Cleveland,
Ohio; Boston, Mass; and Washington, DC
The long-term outcome of patients with corrected transposition who have undergone a classic
surgical approach is unsatisfactory, with only 61% survival at 15 years. The poorest outcome is
seen in patients who require TVR either at their initial operation or later during follow-up.
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